Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 6.40
0.00 (0.00%)
Jun 17, 2026, 8:54 AM GMT
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 68.38 million as of June 16, 2026. Its market cap has increased by 154.92% in one year.
Market Cap
68.38M
Enterprise Value
82.13M
Revenue
36.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 68.38M, a decrease of -59.72%. That is a compound annual growth rate of -8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 68.38M | -34.62% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.84B |
| Hikma Pharmaceuticals | 3.15B |
| HUTCHMED (China) | 1.42B |
| Allergy Therapeutics | 500.27M |
| Venture Life Group | 81.62M |
| ECO Animal Health Group | 62.34M |
| Provexis | 22.05M |
| Chill Brands Group | 1.57M |